The European Medicines Agency (EMA) Validated Regulatory Application for Arpraziquantel, a Potential Treatment for Schistosomiasis in Preschool-Aged Children

Arpraziquantel is the first investigational drug in regulatory phase amongst the different projects supported by the GHIT (Global Health Innovative Technology)...

Related Keywords

Japan ,Kenya ,Germany ,Tokyo ,Netherlands ,United Kingdom ,Brazil ,Switzerland ,Japanese ,Swiss ,Osamu Kunii ,Eriko Mugitani ,Technischen Universit ,Katy Lenard ,Consortium Partners ,Ministry Of Health ,Melinda Gates Foundation ,Global Health Innovative Technology Fund ,Astellas Pharma Inc ,Wellcome ,Public Health Institute Switzerland ,African Institute For Health ,Foundation United Kingdom ,United Nations Development Programme ,World Health Organization ,Global Health Innovative Technology ,Kenya Medical Research Institute ,Development Kenya ,Pediatric Praziquantel Consortium ,European Medicines Agency ,Astellas Pharma ,Saharan African ,Pediatric Praziquantel ,Swiss Tropical ,Public Health Institute ,African Institute ,Saharan Africa ,Health Innovative Technology ,Global Health Innovative Technology Ghit Fund ,